Discouraged Job-Seekers Cite Crisis In Science Career Advice

As available academic researchjobs decline, many are questioning the wisdom of traditional maxims like 'the cream rises to the top' Rapid and accelerating changes in the structure of United States science have left many scientists bitterly disenchanted and feeling that they have been left high and dry, trapped in dead-end careers, the victims of misleading or downright bad career advice. DOUBTER: Kevin Aylesworth says that graduate advisors have a vested interest in keeping students in resear

Written byRobert Finn
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share


As available academic researchjobs decline, many are questioning the wisdom of traditional maxims like 'the cream rises to the top'
Rapid and accelerating changes in the structure of United States science have left many scientists bitterly disenchanted and feeling that they have been left high and dry, trapped in dead-end careers, the victims of misleading or downright bad career advice.


DOUBTER: Kevin Aylesworth says that graduate advisors have a vested interest in keeping students in research.
California Institute of Technology vice provost David Goodstein, a highly successful physicist, describes the current situation this way: "The great corporations no longer believe they need central research labs, and they've been undone. The Cold War has ended. The national labs have lost their missions and haven't found new ones. The world has changed completely."

Many feel that the implications of these changes are being communicated poorly, if at all, to those contemplating scientific ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies